ILEANA SCHROPP: Open Payments
NPI 1043085301 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 31 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,395 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $242 |
| Novo Nordisk Inc | 4 | $149 |
| Teva Pharmaceuticals USA, Inc. | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| PFIZER INC. | 3 | $66 |
| Philips North America LLC | 2 | $54 |
| ABBVIE INC. | 2 | $48 |
| Biogen, Inc. | 2 | $37 |
| Exact Sciences Corporation | 1 | $22 |
Products named: ZEPBOUND, Ozempic, AUSTEDO XR, JARDIANCE, FARXIGA, Vest Therapy Und, MOUNJARO, VRAYLAR.
Industry payments across IL — which companies pay providers there.
